At-risk populations need to be priority beyond vaccine By Patrick J. Kennedy An end to the pandemic is finally in sight. Both Pfizer and Moderna reported that their vaccine candidates are 95 percent effective, and subsequently received emergency use authorization from the FDA. Prioritizing the delivery of vaccines to people most at risk — including…
Pfizer and Biotech Achieve first authorization for vaccine to combat COVID-19 U.K. regulator, MHRA, authorizes supply of COVID-19 mRNA vaccine for emergency supply under Regulation 174; Companies are ready to deliver the first doses to the U.K. immediately. First authorization for a COVID-19 vaccine represents a breakthrough scientific achievement to help combat this devastating pandemic. The companies…
At-risk populations need to be priority beyond vaccine
By Ray Hanania |
At-risk populations need to be priority beyond vaccine By Patrick J. Kennedy An end to the pandemic is finally in sight. Both Pfizer and Moderna reported that their vaccine candidates are 95 percent effective, and subsequently received emergency use authorization from the FDA. Prioritizing the delivery of vaccines to people most at risk — including…
Read more »